Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Ahead of print

Issues

Hereditary hyperferritinaemia-cataract syndrome (HHCS) – an underestimated condition: ferritin light chain variant spectrum in German families

Martin Volkmann / Rudolf Richter / Thomas Herrmann / Sabine Hentze / Michaela Hör / Hendrik Hasche / Barbara Selle / Wolfgang Stremmel / Sven G. Gehrke
Published Online: 2019-06-18 | DOI: https://doi.org/10.1515/cclm-2018-1354

Abstract

Background

In hereditary hyperferritinaemia-cataract syndrome (HHCS), single nucleic acid alterations in the ferritin light chain (L-ferritin) iron response element (IRE) constitutively derepress ferritin synthesis, resulting in hyperferritinaemia, L-ferritin deposits in the lens of the eye and early bilateral cataract onset.

Methods

In this study, six German families with putative HHCS were analysed. Clinical diagnosis of HHCS was based on medical history, evaluation of ferritin serum levels, transferrin saturation and clinical ophthalmological examination. Diagnosis was confirmed by polymerase chain reaction (PCR)-based DNA sequencing of the L-ferritin IRE.

Results

Genetic analysis of the L-ferritin IRE revealed relevant single nucleic acid alterations in each of the affected families. Variants c.-168G > A, c.-168G > U and c.-167C > U were located in the C-bulge region; and variants c.-161C > U and c.-157G > A were located in the hexanucleotide loop of the L-ferritin IRE.

Conclusions

Family history of hyperferritinaemia and juvenile cataracts are strong indicators of HHCS. Genetic analysis of the L-ferritin IRE is a straightforward procedure to confirm the diagnosis. Accurate diagnosis of hyperferritinaemia can avoid unnecessary treatment by venesection, and focus attention on early cataract detection in offspring at risk.

Keywords: cataract; ferritin; hyperferritinaemia; IRE side

References

  • 1.

    Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161–203.PubMedCrossrefGoogle Scholar

  • 2.

    Piperno A. Classification and diagnosis of iron overload. Haematologica 1998;83:447–55.PubMedGoogle Scholar

  • 3.

    Gehrke SG, Stremmel W, Mathes I, Riedel HD, Bents K, Kallinowski B. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. J Mol Med (Berl) 2003;81:780–7.CrossrefPubMedGoogle Scholar

  • 4.

    Beaumont C, Leneuve P, Devaux I, Scoazec JY, Berthier M, Loiseau MN, et al. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet 1995;11:444–6.CrossrefGoogle Scholar

  • 5.

    Cremonesi L, Paroni R, Foglieni B, Galbiati S, Fermo I, Soriani N, et al. Scanning mutations of the 5′UTR regulatory sequence of L-ferritin by denaturing high-performance liquid chromatography: identification of new mutations. Br J Haematol 2003;121:173–9.PubMedCrossrefGoogle Scholar

  • 6.

    Cremonesi L, Fumagalli A, Soriani N, Ferrari M, Levi S, Belloli S, et al. Double-gradient denaturing gradient gel electrophoresis assay for identification of L-ferritin iron-responsive element mutations responsible for hereditary hyperferritinemia-cataract syndrome: identification of the new mutation C14G. Clin Chem 2001;47:491–7.PubMedGoogle Scholar

  • 7.

    Cazzola M, Bergamaschi G, Tonon L, Arbustini E, Grasso M, Vercesi E, et al. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 1997;90:814–21.PubMedGoogle Scholar

  • 8.

    Bosio S, Campanella A, Gramaglia E, Porporato P, Longo F, Cremonesi L, et al. C29G in the iron-responsive element of L-ferritin: a new mutation associated with hyperferritinemia-cataract. Blood Cells Mol Dis 2004;33:31–4.PubMedCrossrefGoogle Scholar

  • 9.

    Kato GJ, Casella F. l-Ferritin Baltimore-1: a novel mutation in the iron responsive element (C32G) as a cause of hyperferritinemia–cataract syndrome. Blood 1999;94:407a.Google Scholar

  • 10.

    Martin ME, Fargion S, Brissot P, Pellat B, Beaumont C. A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome. Blood 1998;91:319–23.Google Scholar

  • 11.

    Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 2003;102:1904–10.CrossrefGoogle Scholar

  • 12.

    Balas A, Aviles MJ, Garcia-Sanchez F, Vicario JL. Description of a new mutation in the L-ferrin iron-responsive element associated with hereditary hyperferritinemia-cataract syndrome in a Spanish family. Blood 1999;93:4020–1.Google Scholar

  • 13.

    Luscieti S, Tolle G, Aranda J, Campos CB, Risse F, Moran E, et al. Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome. Orphanet J Rare Dis 2013;8:30.CrossrefWeb of SciencePubMedGoogle Scholar

  • 14.

    Mumford AD, Vulliamy T, Lindsay J, Watson A. Hereditary hyperferritinemia-cataract syndrome: two novel mutations in the L-ferritin iron-responsive element. Blood 1998;91:367–8.PubMedGoogle Scholar

  • 15.

    Garcia Erce JA, Cortes T, Cremonesi L, Cazzola M, Perez-Lungmus G, Giralt M. Hyperferritinemia-cataract syndrome associated to the HFE gene mutation. Two new Spanish families and a new mutation (A37T: “Zaragoza”). Med Clin (Barc) 2006;127:55–8.Google Scholar

  • 16.

    Millonig G, Muckenthaler MU, Mueller S. Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder. Hum Genomics 2010;4:250–62.PubMedGoogle Scholar

  • 17.

    Garderet L, Hermelin B, Gorin NC, Rosmorduc O. Hereditary hyperferritinemia-cataract syndrome: a novel mutation in the iron-responsive element of the L-ferritin gene in a French family. Am J Med 2004;117:138–9.CrossrefGoogle Scholar

  • 18.

    Craig JE, Clark JB, McLeod JL, Kirkland MA, Grant G, Elder JE, et al. Hereditary hyperferritinemia-cataract syndrome: prevalence, lens morphology, spectrum of mutations, and clinical presentations. Arch Ophthalmol 2003;121:1753–61.CrossrefPubMedGoogle Scholar

  • 19.

    Girelli D, Corrocher R, Bisceglia L, Olivieri O, De Franceschi L, Zelante L, et al. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the “Verona mutation”). Blood 1995;86:4050–3.PubMedGoogle Scholar

  • 20.

    Phillips JD, Warby CA, Kushner JP. Identification of a novel mutation in the L-ferritin IRE leading to hereditary hyperferritinemia-cataract syndrome. Am J Med Genet A 2005;134A:77–9.PubMedCrossrefGoogle Scholar

  • 21.

    Van de Sompele S, Pecheux L, Couso J, Meunier A, Sanchez M, De Baere E. Functional characterization of a novel non-coding mutation “Ghent+49A>G” in the iron-responsive element of L-ferritin causing hereditary hyperferritinaemia-cataract syndrome. Sci Rep 2017;7:18025.Web of ScienceCrossrefGoogle Scholar

  • 22.

    Gonzalez-Huerta L, Ramirez-Sanchez V, Rivera-Vega M, Messina-Baas O, Cuevas-Covarrubias S. A family with hereditary hyperferritinaemia cataract syndrome: evidence of incomplete penetrance and clinical heterogeneity. Br J Haematol 2008;143:596–8.Web of SciencePubMedGoogle Scholar

  • 23.

    Camaschella C, Zecchina G, Lockitch G, Roetto A, Campanella A, Arosio P, et al. A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. Br J Haematol 2000;108:480–2.PubMedCrossrefGoogle Scholar

  • 24.

    Ferrari F, Foglieni B, Arosio P, Camaschella C, Daraio F, Levi S, et al. Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large-scale analysis of disorders of iron metabolism. Hum Mutat 2006;27:201–8.PubMedCrossrefGoogle Scholar

  • 25.

    Allerson CR, Cazzola M, Rouault TA. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem 1999;274:26439–47.CrossrefPubMedGoogle Scholar

  • 26.

    Mumford AD, Cree IA, Arnold JD, Hagan MC, Rixon KC, Harding JJ. The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin. Br J Ophthalmol 2000;84:697–700.CrossrefPubMedGoogle Scholar

  • 27.

    Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res 2000;10:1031–42.CrossrefPubMedGoogle Scholar

  • 28.

    Girelli D, Olivieri O, De Franceschi L, Corrocher R, Bergamaschi G, Cazzola M. A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol 1995;90:931–4.CrossrefPubMedGoogle Scholar

  • 29.

    Millonig G, Holzer MP, Tolle G, Auffarth GU, Muckenthaler MU, Seitz HK, et al. Hereditary hyperferritinemia cataract syndrome – the first family in Germany. Z Gastroenterol 2009;47:1211.Web of SciencePubMedGoogle Scholar

  • 30.

    Nonnenmacher L, Langer T, Blessing H, Gabriel H, Buchwald HJ, Meneksedag C, et al. Hereditary hyperferritinemia cataract syndrome: clinical, genetic, and laboratory findings in 5 families. Klin Padiatr 2011;223:346–51.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 31.

    Jaffrey SR, Haile DJ, Klausner RD, Harford JB. The interaction between the iron-responsive element binding protein and its cognate RNA is highly dependent upon both RNA sequence and structure. Nucleic Acids Res 1993;21:4627–31.PubMedCrossrefGoogle Scholar

  • 32.

    Wirth MG, Russell-Eggitt IM, Craig JE, Elder JE, Mackey DA. Aetiology of congenital and paediatric cataract in an Australian population. Br J Ophthalmol 2002;86:782–6.CrossrefGoogle Scholar

  • 33.

    Javadiyan S, Craig JE, Souzeau E, Sharma S, Lower KM, Mackey DA, et al. High-throughput genetic screening of 51 pediatric cataract genes identifies causative mutations in inherited pediatric cataract in South Eastern Australia. G3 (Bethesda) 2017;7:3257–68.PubMedCrossrefGoogle Scholar

  • 34.

    Ma AS, Grigg JR, Ho G, Prokudin I, Farnsworth E, Holman K, et al. Sporadic and familial congenital cataracts: mutational spectrum and new diagnoses using next-generation sequencing. Hum Mutat 2016;37:371–84.Web of SciencePubMedCrossrefGoogle Scholar

  • 35.

    Messina-Baas O, Cuevas-Covarrubias SA. Inherited congenital cataract: a guide to suspect the genetic etiology in the cataract genesis. Mol Syndromol 2017;8:58–78.Web of SciencePubMedCrossrefGoogle Scholar

  • 36.

    Wang YG, Sun SP, Qiu YL, Xing QH, Lu W. A novel mutation in EYA1 in a Chinese family with branchio-oto-renal syndrome. BMC Med Genet 2018;19:139.CrossrefWeb of ScienceGoogle Scholar

  • 37.

    Li B, Xu L, Hong N, Chen S, Xu R. In silico analyses reveal the relationship between SIX1/EYA1 mutations and conotruncal heart defects. Pediatr Cardiol 2018;39:176–82.CrossrefWeb of SciencePubMedGoogle Scholar

  • 38.

    Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139–200.PubMedGoogle Scholar

  • 39.

    Barton JC, Bertoli LF, Janich MR, Arthur MW, Alford TJ. Normal transferrin saturation in hemochromatosis. Hosp Pract (Off Ed) 1991;26(Suppl 3):46–8.PubMedGoogle Scholar

  • 40.

    Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95–7.PubMedCrossrefGoogle Scholar

  • 41.

    Barton JC, Beutler E, Gelbart T. Coinheritance of alleles associated with hemochromatosis and hereditary hyperferritinemia-cataract syndrome. Blood 1998;92:4480.PubMedGoogle Scholar

  • 42.

    Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.PubMedCrossrefGoogle Scholar

  • 43.

    Moirand R, Guyader D, Mendler MH, Jouanolle AM, Le Gall JY, David V, et al. HFE based re-evaluation of heterozygous hemochromatosis. Am J Med Genet 2002;111:356–61.PubMedCrossrefGoogle Scholar

  • 44.

    Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 – the right to sight. Bull World Health Organ 2001;79:227–32.PubMedGoogle Scholar

  • 45.

    Magnusson G, Haargaard B, Basit S, Lundvall A, Nystrom A, Rosensvard A, et al. The Paediatric Cataract Register (PECARE): an overview of operated childhood cataract in Sweden and Denmark. Acta Ophthalmol 2018;96:51–5.CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Corresponding author: PD Dr. Martin Volkmann, MVZ Labor PD Dr. Volkmann & Kollegen GbR, Kriegsstr. 99, D-76133 Karlsruhe, Germany


Received: 2018-12-20

Accepted: 2019-05-19

Published Online: 2019-06-18


Funding Source: Deutsche Forschungsgemeinschaft

Award identifier / Grant number: STR 216/10-1

Supported by grant no: STR 216/10-1 (funder Id: http://dx.doi.org/10.13039/501100001659) of the Deutsche Forschungsgemeinschaft and the Dietmar Hopp Foundation.


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), 20181354, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-1354.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in